Literature DB >> 19053772

Bisphosphonate inhibition of a Plasmodium farnesyl diphosphate synthase and a general method for predicting cell-based activity from enzyme data.

Dushyant Mukkamala1, Joo Hwan No, Lauren M Cass, Ting-Kai Chang, Eric Oldfield.   

Abstract

We screened 26 bisphosphonates against a farnesyl diphosphate synthase from Plasmodium vivax, finding a poor correlation between enzyme and cell growth inhibition (R(2) = 0.06). To better predict cell activity data, we then used a combinatorial descriptor search in which pIC(50)(cell) = a pIC(50)(enzyme) + bB + cC + d, where B and C are descriptors (such as SlogP), and a-d are coefficients. R(2) increased from 0.01 to 0.74 (for a leave-two-out test set of 26 predictions). The method was then further validated using data for nine other systems, including bacterial, viral, and mammalian cell systems. On average, experimental/predicted cell pIC(50) correlations increased from R(2) = 0.28 (for an enzyme-only test set) to 0.70 (for enzyme plus two descriptor test set predictions), while predictions based on scrambled cell activity had no predictive value (R(2) = 0.13). These results are of interest since they represent a general way to predict cell from enzyme inhibition data, with in three cases, R(2) values increasing from approximately 0.02 to 0.72.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053772      PMCID: PMC2765246          DOI: 10.1021/jm8009074

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

Authors:  J E Dunford; K Thompson; F P Coxon; S P Luckman; F M Hahn; C D Poulter; F H Ebetino; M J Rogers
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

2.  Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.

Authors:  A Montalvetti; B N Bailey; M B Martin; G W Severin; E Oldfield; R Docampo
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

3.  Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

Authors:  M B Martin; J S Grimley; J C Lewis; H T Heath; B N Bailey; H Kendrick; V Yardley; A Caldera; R Lira; J A Urbina; S N Moreno; R Docampo; S L Croft; E Oldfield
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

4.  In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.

Authors:  Vanessa Yardley; Anis A Khan; Michael B Martin; Teri R Slifer; Fausto G Araujo; Silvia N J Moreno; Roberto Docampo; Simon L Croft; Eric Oldfield
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies.

Authors:  Andrea Montalvetti; Alexis Fernandez; John M Sanders; Subhash Ghosh; Erin Van Brussel; Eric Oldfield; Roberto Docampo
Journal:  J Biol Chem       Date:  2003-03-04       Impact factor: 5.157

6.  4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity.

Authors:  Alfonso de Dios; Lourdes Prieto; Jose Alfredo Martín; Almudena Rubio; Jesus Ezquerra; Mark Tebbe; Beatriz López de Uralde; Justina Martín; Ana Sánchez; Deborah L LeTourneau; James E McGee; Carole Boylan; Thomas R Parr; Michele C Smith
Journal:  J Med Chem       Date:  2002-09-26       Impact factor: 7.446

7.  An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.

Authors:  Christina M Szabo; Michael B Martin; Eric Oldfield
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

8.  3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.

Authors:  John M Sanders; Aurora Ortiz Gómez; Junhong Mao; Gary A Meints; Erin M Van Brussel; Agnieszka Burzynska; Pawel Kafarski; Dolores González-Pacanowska; Eric Oldfield
Journal:  J Med Chem       Date:  2003-11-20       Impact factor: 7.446

9.  Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.

Authors:  Subhash Ghosh; Julian M W Chan; Christopher R Lea; Gary A Meints; Jared C Lewis; Zev S Tovian; Ryan M Flessner; Timothy C Loftus; Iris Bruchhaus; Howard Kendrick; Simon L Croft; Robert G Kemp; Seiki Kobayashi; Tomoyoshi Nozaki; Eric Oldfield
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

10.  Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.

Authors:  James E Dunford; Aaron A Kwaasi; Michael J Rogers; Bobby L Barnett; Frank H Ebetino; R Graham G Russell; Udo Oppermann; Kathryn L Kavanagh
Journal:  J Med Chem       Date:  2008-03-08       Impact factor: 7.446

View more
  22 in total

1.  Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth.

Authors:  Agam Prasad Singh; Yonghui Zhang; Joo-Hwan No; Roberto Docampo; Victor Nussenzweig; Eric Oldfield
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  In Vitro and in Vivo Activity of Multitarget Inhibitors against Trypanosoma brucei.

Authors:  Gyongseon Yang; Wei Zhu; Yang Wang; Guozhong Huang; Soo Young Byun; Gahee Choi; Kai Li; Zhuoli Huang; Roberto Docampo; Eric Oldfield; Joo Hwan No
Journal:  ACS Infect Dis       Date:  2015-07-31       Impact factor: 5.084

3.  In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.

Authors:  Gyongseon Yang; Wei Zhu; Kuglae Kim; Soo Young Byun; Gahee Choi; Ke Wang; Jeong Seok Cha; Hyun-Soo Cho; Eric Oldfield; Joo Hwan No
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.

Authors:  Joo Hwan No; Fernando de Macedo Dossin; Yonghui Zhang; Yi-Liang Liu; Wei Zhu; Xinxin Feng; Jinyoung Anny Yoo; Eunhae Lee; Ke Wang; Raymond Hui; Lucio H Freitas-Junior; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

5.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Bacterial Cell Growth Inhibitors Targeting Undecaprenyl Diphosphate Synthase and Undecaprenyl Diphosphate Phosphatase.

Authors:  Yang Wang; Janish Desai; Yonghui Zhang; Satish R Malwal; Christopher J Shin; Xinxin Feng; Hong Sun; Guizhi Liu; Rey-Ting Guo; Eric Oldfield
Journal:  ChemMedChem       Date:  2016-08-31       Impact factor: 3.466

7.  Use of thermal melt curves to assess the quality of enzyme preparations.

Authors:  Gregory J Crowther; Panqing He; Philip P Rodenbough; Andrew P Thomas; Kuzma V Kovzun; David J Leibly; Janhavi Bhandari; Lisa J Castaneda; Wim G J Hol; Michael H Gelb; Alberto J Napuli; Wesley C Van Voorhis
Journal:  Anal Biochem       Date:  2009-12-14       Impact factor: 3.365

8.  Chemical Exchange Saturation Transfer (CEST) Agents: Quantum Chemistry and MRI.

Authors:  Jikun Li; Xinxin Feng; Wei Zhu; Nikita Oskolkov; Tianhui Zhou; Boo Kyung Kim; Noman Baig; Michael T McMahon; Eric Oldfield
Journal:  Chemistry       Date:  2015-11-30       Impact factor: 5.236

9.  Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis.

Authors:  Yonghui Zhang; Wei Zhu; Yi-Liang Liu; Hong Wang; Ke Wang; Kai Li; Joo Hwan No; Lawrence Ayong; Anmol Gulati; Ran Pang; Lucio Freitas-Junior; Craig T Morita; Eric Old-Field
Journal:  ACS Med Chem Lett       Date:  2013-04-11       Impact factor: 4.345

10.  Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

Authors:  Germán Plata; Tzu-Lin Hsiao; Kellen L Olszewski; Manuel Llinás; Dennis Vitkup
Journal:  Mol Syst Biol       Date:  2010-09-07       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.